Quick Answer
BALCHEM CORP reported Cash And Cash Equivalents At Carrying Value of $74.57 million for the year ending 2025.
- BALCHEM CORP showed an increase of +50.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from BALCHEM CORP's annual report (Form 10-K), filed with the SEC on February 20, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), BALCHEM CORP's Cash And Cash Equivalents At Carrying Value has grown by 2,079.1%.
- Historical annual values: Fiscal year 2025: $74.57 million | Fiscal year 2024: $49.52 million | Fiscal year 2023: $64.45 million | Fiscal year 2022: $66.56 million | Fiscal year 2021: $103.24 million | Fiscal year 2020: $84.57 million | Fiscal year 2019: $65.67 million | Fiscal year 2018: $54.27 million | Fiscal year 2017: $40.42 million | Fiscal year 2016: $38.64 million | Fiscal year 2015: $84.80 million | Fiscal year 2014: $50.29 million | Fiscal year 2013: $208.75 million | Fiscal year 2012: $144.74 million | Fiscal year 2011: $114.78 million | Fiscal year 2010: $77.25 million | Fiscal year 2009: $46.43 million | Fiscal year 2008: $3.42 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: